D. Scott Neal, Inc. Abbott Laboratories Transaction History
D. Scott Neal, Inc.
- $182 Million
- Q4 2024
A detailed history of D. Scott Neal, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, D. Scott Neal, Inc. holds 2,900 shares of ABT stock, worth $384,685. This represents 0.18% of its overall portfolio holdings.
Number of Shares
2,900
Previous 2,900
-0.0%
Holding current value
$384,685
Previous $330,000
0.61%
% of portfolio
0.18%
Previous 0.18%
Shares
6 transactions
Others Institutions Holding ABT
# of Institutions
3,379Shares Held
1.33BCall Options Held
10.6MPut Options Held
8.72M-
Vanguard Group Inc Valley Forge, PA169MShares$22.4 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.2 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$9.02 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.18 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $232B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...